Hyperphenylalaninemia (HPA) due to tetrahydrobiopterin (BH4) deficiency, also known as malignant HPA is an amino acid disorder with neonatal onset that is clinically characterized by the classic manifestations of phenylketonuria (PKA) and that later on is clinically differentiated by neurologic symptoms such as microcephaly, intellectual disability, central hypotonia, delayed motor development, peripheral spasticity and seizures, that develop and persist despite an established metabolic control of plasma phenylalanine.
Comprehensive, easy-to-understand information about this condition
Checking for content...
immunodeficiency-centromeric instability-facial anomalies syndrome
MONDO:0000133
hypercalcemia, infantile
MONDO:0000212
disorder of methionine catabolism
MONDO:0000351
inborn serine deficiency
MONDO:0000421
cerebral creatine deficiency syndrome
MONDO:0000456
Ochoa syndrome
MONDO:0000463